167 related articles for article (PubMed ID: 25674720)
21. An audience with Tatiana Prowell. Interviewed by Asher Mullard.
Prowell T
Nat Rev Drug Discov; 2014 Jun; 13(6):410-1. PubMed ID: 24875091
[No Abstract] [Full Text] [Related]
22. Leaders worry that U.S. is losing edge on cancer clinical trials.
Twombly R
J Natl Cancer Inst; 2008 Sep; 100(17):1196-9. PubMed ID: 18728275
[No Abstract] [Full Text] [Related]
23. The National Cancer Institute's transdisciplinary centers initiatives and the need for building a science of team science.
Croyle RT
Am J Prev Med; 2008 Aug; 35(2 Suppl):S90-3. PubMed ID: 18619408
[No Abstract] [Full Text] [Related]
24. National Cancer Institute-sponsored cooperative groups: changing process to speed progress.
Montello M; Mooney M; Denicoff A; Adler J; Goldberg J; Abrams J
Clin Lymphoma Myeloma; 2009 Jun; 9(3):194-6. PubMed ID: 19525187
[No Abstract] [Full Text] [Related]
25. National Cancer Institute helps businesses cross 'the valley of death'.
Nair P
Nat Med; 2008 Aug; 14(8):795. PubMed ID: 18685581
[No Abstract] [Full Text] [Related]
26. Research probes anticancer mechanisms of Polyphenon E.
Graff S
J Natl Cancer Inst; 2009 May; 101(9):627-8. PubMed ID: 19401557
[No Abstract] [Full Text] [Related]
27. The role of the National Cancer Institute in drug development.
Doroshow J
Clin Adv Hematol Oncol; 2005 Apr; 3(4):257-8. PubMed ID: 16166997
[No Abstract] [Full Text] [Related]
28. Newsmaker interview: Harold Varmus. Piloting cancer research with a shrinking budget. Interview by Jocelyn Kaiser.
Varmus H
Science; 2011 Jul; 333(6041):397. PubMed ID: 21778374
[No Abstract] [Full Text] [Related]
29. The National Cancer Institute's Clinical Trials Innovation Unit.
Morris MJ; Prindiville S
Clin Adv Hematol Oncol; 2023 Dec; 21(12):663-665. PubMed ID: 38039060
[No Abstract] [Full Text] [Related]
30. NCI seeks to speed drug development for pediatric cancers: New initiative aims to help prioritize agents with most potential.
Printz C
Cancer; 2016 Feb; 122(4):499-500. PubMed ID: 26844936
[No Abstract] [Full Text] [Related]
31. Historical background of the National Cancer Institute's drug development thrust.
Zubrod CG; Schepartz SA; Carter SK
Natl Cancer Inst Monogr; 1977 Mar; (45):7-11. PubMed ID: 337156
[No Abstract] [Full Text] [Related]
32. Overview of U.S. National Cancer Institute (USNCI) chemoprevention research.
Johnson KA; Ford LG; Kramer B; Greenwald P
Acta Oncol; 1994; 33(1):5-11. PubMed ID: 8142125
[TBL] [Abstract][Full Text] [Related]
33. The National Cancer Institute's Experimental Therapeutics Clinical Trials Network.
Ivy SP
Clin Adv Hematol Oncol; 2015 Mar; 13(3):144-6. PubMed ID: 26352418
[No Abstract] [Full Text] [Related]
34. United States military contributions to the National Cancer Institute.
Sarvis JA; Thompson IM
Urol Oncol; 2009; 27(5):558-61. PubMed ID: 19720303
[TBL] [Abstract][Full Text] [Related]
35. Cancer and AIDS: National Cancer Institute's investment in research.
Feigal EG; Black JB
Res Initiat Treat Action; 2003; 9(1):26-9. PubMed ID: 14971363
[No Abstract] [Full Text] [Related]
36. Clinical trials: a recent emphasis in the prevention program of the National Cancer Institute.
DeWys WD; Greenwald P
Semin Oncol; 1983 Sep; 10(3):360-4. PubMed ID: 6665563
[No Abstract] [Full Text] [Related]
37. Opportunities for the ECOG-ACRIN Cancer Research Group within the new National Clinical Trials Network.
Comis RL; Schnall MD
Semin Oncol; 2015 Feb; 42(1):1-3. PubMed ID: 25726046
[No Abstract] [Full Text] [Related]
38. What happened to the US cancer cooperative groups? A status update ten years after the Institute of Medicine report.
Bertagnolli MM; Blanke CD; Curran WJ; Hawkins DS; Mannel RS; O'Dwyer PJ; Schnall MD; Wolmark N
Cancer; 2020 Dec; 126(23):5022-5029. PubMed ID: 32970346
[TBL] [Abstract][Full Text] [Related]
39. Report of the Cancer Chemotherapy Collaborative Program Review Committee: the Richardson report. June 1966, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Cancer Treat Rep; 1984 Jan; 68(1):343-56. PubMed ID: 6692435
[No Abstract] [Full Text] [Related]
40. Can We Find the Positive in Negative Clinical Trials?
Allegra CJ; Goodwin PJ; Ganz PA
J Natl Cancer Inst; 2019 Jul; 111(7):637-638. PubMed ID: 31077298
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
